Affiliation:
1. Department of Pharmacy, School of Pharmacy, Phase I Clinical Trial Centre, The Affiliated Changsha Central Hospital, Hengyang Medical School University of South China Changsha China
2. Hunan Provincial Key Laboratory of Tumor Microenvironment Responsive Drug Research School of Pharmacy of University of South China Hengyang China
Abstract
AbstractIsoliensinine (ISO), a natural compound, is a bibenzyl isoquinoline alkaloid monomer in lotus seed, which has strong antioxidant and free radical scavenging activities. The oxidative toxicity caused by glutamic acid overdose is one of the important mechanisms of nerve cell injury, and the oxidative toxicity caused by glutamic acid is related to ferroptosis. This study aims to establish a glutamate‐induced injury model of mouse hippocampal neurons HT‐22 cells, and investigate the protective effect of ISO on the neurotoxicity of glutamate‐induced HT‐22 cells. The results showed that ISO inhibited glutamate‐induced ferroptosis of neuronal cells through nuclear factor E2‐related factor 2/glutathione peroxidase 4 (Nrf2/GPX4) signaling pathway. Pretreatment of HT‐22 cells with ISO significantly reduced glutamate‐induced cell death. Ferroptosis inhibitors have the same effect. ISO inhibited the decrease of mitochondrial membrane potential detection and the increase of iron content induced by glutamate, the increase of malondialdehyde and reactive oxygen species in cytoplasm and lipid, and protected the activities of GPx and superoxide dismutase enzymes. In addition, WB showed that glutamic acid could induce the upregulated expression of long‐chain esteryl coA synthase 4 (ACSL4) protein and the downregulated expression of SLC7A11 and GPX4 protein in HT‐22 cells, while ISO could prevent the abnormal expression of these proteins induced by glutamic acid. The nuclear translocation of Nrf2 in HT‐22 cells was increased, and the expression of downstream heme oxygenase‐1 protein was upregulated. In summary, ISO protects HT‐22 cells from glutamate‐induced ferroptosis through a novel mechanism of the Nrf2/GPX4 signaling pathway.